Cancer clinical trials in the region Bretagne
146 currently recruiting clinical trials
If you are a doctor and would like find matching clinical trials for you patients, create an account or log in
If you are a patient and would like to know if you may participate in a clinical trial, please consult your doctor so that he can send your file to a matching trial
Early Access
Lung cancer
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
EGFR
Targeted therapy
Systemic Treatment-Naive
Janssen
Early Access
Lung cancer
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
EGFR
None
Systemic Treatment-Naive
Janssen
Early Access
Lung cancer
NSCLC (Non-Small Cell Lung Cancer)
Non-squamous NSCLC
Locally Advanced
EGFR
None
Chemotherapy
Radiotherapy
AstraZeneca
Early Access
Lung cancer
NSCLC (Non-Small Cell Lung Cancer)
Localized
ALK
None
Systemic Treatment-Naive
Surgery
Hoffmann-La Roche
Early Access
Lung cancer
NSCLC (Non-Small Cell Lung Cancer)
Localized
PDL1 Positive (1% <= X < 25%)
PDL1 Positive (25% <= X < 50%)
PDL1 Positive (>= 50%)
None
Systemic Treatment-Naive
ALK
EGFR
Bristol-Myers Squibb
Early Access
Lung cancer
SCLC (Small Cell Lung Cancer)
Localized
Locally Advanced
None
Chemotherapy
Radiotherapy
Chemotherapy
Radiotherapy
AstraZeneca
Phase 3
Breast cancer
#NCT06760637
HER2 Negative
HR Positive
Locally Advanced
Metastatic
None
Systemic Treatment-Naive
Centre Eugene Marquis (Rennes)
Pfizer
Phase 3
Bladder / Urinary Tract / Urethral cancer
#NCT06319820
Non-invasive bladder cancer
Localized
FGFR
None
1
2
3 or more
CHU de Rennes - Hôpital Pontchaillou (Rennes)
Janssen
Phase 3
Lung cancer
#NCT06635824
NSCLC (Non-Small Cell Lung Cancer)
Metastatic
PDL1 Positive (1% <= X < 25%)
PDL1 Positive (25% <= X < 50%)
PDL1 Positive (>= 50%)
1
2
Immunotherapy
Chemotherapy
ALK
BRAF
EGFR
KRAS G12C
KRAS non G12C
MET
RET
ROS-1
Systemic Treatment-Naive
Car-T
CHU de Rennes - Hôpital Pontchaillou (Rennes)
Genmab
Phase 3
Stomach and esophageal cancer
#NCT06346392
Stomach
Oesogastric junction
Esophagus
Adenocarcinoma
Locally Advanced
Metastatic
Claudin 18.2
1
2
3 or more
Chemotherapy
HER2
Systemic Treatment-Naive
Centre Hospitalier Régional Et Universitaire CHRU de Brest (Brest)
AstraZeneca